2 most recent filings and news items mentioning INDV. Updated every 60 seconds.
Earnings|Guidance|M&AAug 3, 2026Positive
Indivior posted record quarterly net revenues and raised 2026 full-year guidance driven by strong SUBLOCADE performance. The company also announced a merger agreement with Supernus Pharmaceuticals.
View filing at SEC.gov →
M&AAug 3, 2026Neutral
Indivior Pharmaceuticals, Inc. has entered into an agreement and plan of merger with Supernus Pharmaceuticals, Inc., marking a strategic acquisition to expand its product portfolio and market presence.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.